Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma (Q40180313)

18 September 2017

Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma (English)

1 reference

18 September 2017

Jiawei Zheng

1

1 reference

18 September 2017

Shanshan Huang

2

1 reference

18 September 2017

Yufang Huang

3

1 reference

18 September 2017

Li Song

4

1 reference

18 September 2017

Yin Yin

5

1 reference

18 September 2017

Wencui Kong

6

1 reference

18 September 2017

Xiong Chen

7

1 reference

18 September 2017

Xuenong Ouyang

8

1 reference

18 September 2017

23 December 2015

1 reference

18 September 2017

1 reference

18 September 2017

37

1 reference

18 September 2017

6

1 reference

18 September 2017

7853-7859

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4675-5

18 September 2017

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Survival in population-based pancreatic cancer patients: San Francisco Bay area, 1995-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Role of protein tyrosine phosphatases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

The tyrosine phosphatase SHP2 regulates focal adhesion kinase to promote EGF-induced lamellipodia persistence and cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

The role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Shp2-mediated molecular signaling in control of embryonic stem cell self-renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Expression and clinical significance of SHP2 in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Critical role of Shp2 in tumor growth involving regulation of c-Myc

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Shp2 function in hematopoietic stem cell biology and leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

The tyrosine phosphatase Shp2 (PTPN11) in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Src homology phosphotyrosyl phosphatase-2 expression is an independent negative prognostic factor in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

The role of Shp2 (PTPN11) in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology in vitro and tumor formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

The tyrosine phosphatase Shp2 in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

How to make tubes: signaling by the Met receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4675-5

SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion

21 January 2018

1 reference

12 December 2020

Expression and clinical significance of SHP2 in the tumor tissues of smokers with lung cancer

1 reference

12 December 2020

Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer

1 reference

12 December 2020

Overexpression of SHP2 tyrosine phosphatase promotes the tumorigenesis of breast carcinoma

1 reference

12 December 2020

10.1007/S13277-015-4675-5

Identifiers

DOI

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference